Cargando…

Antibiotic-Free Selection in Biotherapeutics: Now and Forever

The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignon, Charlotte, Sodoyer, Régis, Werle, Bettina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493468/
https://www.ncbi.nlm.nih.gov/pubmed/25854922
http://dx.doi.org/10.3390/pathogens4020157
_version_ 1782379921435262976
author Mignon, Charlotte
Sodoyer, Régis
Werle, Bettina
author_facet Mignon, Charlotte
Sodoyer, Régis
Werle, Bettina
author_sort Mignon, Charlotte
collection PubMed
description The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world.
format Online
Article
Text
id pubmed-4493468
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44934682015-07-07 Antibiotic-Free Selection in Biotherapeutics: Now and Forever Mignon, Charlotte Sodoyer, Régis Werle, Bettina Pathogens Review The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world. MDPI 2015-04-03 /pmc/articles/PMC4493468/ /pubmed/25854922 http://dx.doi.org/10.3390/pathogens4020157 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mignon, Charlotte
Sodoyer, Régis
Werle, Bettina
Antibiotic-Free Selection in Biotherapeutics: Now and Forever
title Antibiotic-Free Selection in Biotherapeutics: Now and Forever
title_full Antibiotic-Free Selection in Biotherapeutics: Now and Forever
title_fullStr Antibiotic-Free Selection in Biotherapeutics: Now and Forever
title_full_unstemmed Antibiotic-Free Selection in Biotherapeutics: Now and Forever
title_short Antibiotic-Free Selection in Biotherapeutics: Now and Forever
title_sort antibiotic-free selection in biotherapeutics: now and forever
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493468/
https://www.ncbi.nlm.nih.gov/pubmed/25854922
http://dx.doi.org/10.3390/pathogens4020157
work_keys_str_mv AT mignoncharlotte antibioticfreeselectioninbiotherapeuticsnowandforever
AT sodoyerregis antibioticfreeselectioninbiotherapeuticsnowandforever
AT werlebettina antibioticfreeselectioninbiotherapeuticsnowandforever